Specialty CRO Alan Laboratories operates as a specialty contract research organization focused on sustained-release, extended-release, and delayed-release solid dose formulation technologies, presenting a niche for pharmaceutical and biotech firms seeking advanced formulation capabilities.

Formulation Expertise The company provides analytical, pre-formulation and formulation services to develop hard-to-formulate or controlled-release products, offering potential for partnerships on challenging projects and 505(b)(2) NDA candidates.

Strategic Collaborations Long-term collaborations with multiple pharmaceutical companies since 2013 indicate a track record of relationship-driven opportunities, suggesting potential for expanded scope or repeat engagements with existing industry partners.

Growth Indicators Revenue is in the low mid-range for a small biotech CRO with 2-10 employees, signaling opportunity to scale through additional projects, service line expansion, or regional client acquisition in San Diego and beyond.

Tech & Security Digital presence and modern tech stack (including Node.js, Preact, and security measures) support scalable service delivery and potential for online collaboration, client portals, or secure data sharing to attract pharma clients prioritizing compliance and efficiency.